Compartilhar
Informação da revista
Vol. 93. Núm. 1.
Páginas 158-159 (1 janeiro 2018)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 93. Núm. 1.
Páginas 158-159 (1 janeiro 2018)
Open Access
Topical corticosteroid therapy: a treatment option for nevus lipomatosus cutaneous superficialis?*
Visitas
4358
Rafaella Daboit Castagna1, Lia Natália Diehl Dallazem2, Ana Maria Benvegnú2, Catiussa Spode Brutti3
1 Private Practice – Lages (SC), Brazil.
2 Department of Internal Medicine, Universidade Federal de Santa Maria (UFSM) – Santa Maria (RS), Brazil.
3 Department of Dermatology, Hospital Universitário de Santa Maria, Universidade Federal de Santa Maria (HUSM-UFSM) – Santa Maria (RS), Brazil.
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (3)
Mostrar maisMostrar menos
Texto Completo

Dear editor,

The nevus lipomatosus cutaneous superficialis (NLCS) is a rare benign hamartomatous tumor.1–3 It presents in two clinical forms: the classic and the solitary. The classic form usually occurs in childhood and adolescence and is characterized by multiple asymptomatic, soft, cerebriform, pedunculated, yellow or skin-colored papules, nodules or plaques.3 The solitary form is uncommon and usually affects individuals older than 20 years of age; it presents as a single sessile papule or dome-shaped lesion.1

The treatment option is usually motivated by cosmetic purposes, because there are no systemic consequences nor associated malignant tumors. Surgical excision is an appropriate option if the patient decides to treat.1,4 We report an unusual case of classic NLCS, with onset in an atypical age group that had satisfactory clinical response with topical corticosteroid treatment.

Female, 52-year-old patient, smoker, presented with the lesion on the back for almost 2 years. In hot days and with sun exposure, the lesion became itchy with development of erythema and edema. Physical examination revealed a yellow plaque formed by multiple pedunculated and confluent papules, measuring 7 cm x 10 cm, on the right infrascapular region, following the Blaschko’s lines, not crossing the median line (Figure 1). Darier sign was negative. Initial differential diagnosis were solitary mastocytoma, neurofibroma, cutaneous leiomyoma and Shagreen patch. A punch n.º 4 biopsy was performed and the histopathology revealed mast cells in the subtle superficial and interstitial perivascular inflammatory infiltrate, suggestive of cutaneous mastocytosis. We prescribed fludroxycortide (0.125 mg/g) cream whenever the lesion became itchy. The patient used the medication almost daily for four months, with improvement of the symptoms and partial involution of the lesion (Figure 2). Despite worsening with heat and sun exposure, the clinical aspect and the course of the lesion were not typical of cutaneous mastocytosis, so we suspected NLCS. A new incisional biopsy was performed (ellipse) and the histopathology revealed mature fax tissue in the dermis, more prominent around the vessels and associated to dermal perivascular and interstitial mast cells – findings there are consistent with NLCS (Figure 3). We opted not to perform surgery due to the regression of the lesion with topical corticosteroid treatment and the lack of symptoms.

Figure 1.

Subtly yellow plaque, made by multiple pedunculated and confluent papules on the right infrascapular region

(0.05MB).
Figure 2.

Clinical improvement after 4 months of topical corticotherapy

(0.03MB).
Figure 3.

Mature fat tissue in the dermis, more prominent around the vessels and associated to the presence of perivascular and interstitial dermal mast cells (Hematoxylin & eosin, X40)

(0.1MB).

NLCS was first described by Hoffmann and Zurhelle in 1921.1 It is a benign and idiopathic malformation, characterized by the presence of mature ectopic fat tissue among the collagen bundles in the dermis.4 Familial occurrence was not seen, and neither was gender predilection or association with other systemic conditions.2

There are two forms of NLCS: the classical form, described by Hoffmann and Zurhelle, and the soliand the solitary form, both with chronic and asymptomatic course.1,4 In the classical form, multiple papules are seen, coalescing into plaques, with a zosteriform, linear or segmental distribution. They are skin colored or yellow, soft or with a cerebriform surface, and can reach large dimensions. They are located on the upper thighs, buttocks and on the lumbar region, are usually unilateral and are present at birth or in the first 2 decades of life.2,3,5 The solitary form arises from 30 to 50 years of age and is characterized by an isolated sessile or dome-shaped papule on any part of the body surface, but predominantly on the lower trunk, knees, axillae, upper limbs, earlobes and scalp.4

The diagnosis is based on the clinical suspicion and confirmation by histopathology. The histopathology reveals mature ectopic adipocytes interspersed with collagen bundles and proliferating around the periadnexal adventitious dermis and perivascular area. The mature adipocytes proliferate in the reticular dermis and extend to the papillary dermis, without connecting to the subcutaneous fat tissue.2 When there is extensive ectopic build-up of the mature adipocytes in the dermis, the area between the end of the dermis and beginning of the subcutaneous tissue is not clear. Therefore, a larger sample of tissue was paramount in allowing a more precise demarcation by the pathologist.

Treatment is essentially aesthetic and surgical excision is an adequate option.1 Non-surgical treatment options include cryotherapy, CO2 ablative laser and intralesional injections of phosphatidylcholine and sodium deoxycholate, with satisfactory clinical and histologic response.2,3

We report a case of classic NLCS that developed in the 5th decade of life – unusual age group –, that evolved with pruritus, contrary to the commonly asymptomatic course of the lesion. There is no report of the use of topical corticosteroids for the treatment of NLCS in the literature. In the case reported, the lesion improved significantly from the symptoms and clinical aspect after using fludroxycortide.

The case reported brings a new conception in regards to the use of topical corticotherapy for NLCS cases, that needs more clarification, but that elicits the possibility of a new safe, effective and non-invasive treatment, that can be particularly useful for large lesions.

Financial support: None.

Conflict of interests: None.

References
[1.]
Dudani S., Malik A..
Mani NS.Nevus Lipomatosis Cutaneous Superficialis - A clinicopathologic study of the solitary type.
Med J Armed Forces India, 72 (2016), pp. 67-70
[2.]
Goucha S., Khaled A., Zéglaoui F, Rammeh S., Zermani R., Fazaa B..
Nevus Lipomatosus Cutaneous Superficialis: Report of Eight Cases.
Dermatol Ther (Heidelb), 1 (2011), pp. 25-30
[3.]
Kim H.S., Park Y.M., Kim H.O., Lee J.Y..
Intralesional phosphatidylcholine and sodium deoxycholate: a possible treatment option for nevus lipomatosus superficialis..
Pediatr Dermatol, 29 (2012), pp. 119-121
[4.]
Pujani M., Choudhury M., Garg T., Madan N.K..
Nevus lipomatosus superficialis: A rare cutaneous hamartoma.
Indian Dermatol Online J, 5 (2014), pp. 109-110
[5.]
Jung S.T., Park H.W., Yun S.J..
Giant nevus lipomatosus cutaneous superficialis with intramuscular lipomatosis.
J Am Acad Dermatol, 67 (2012), pp. e168-70

Study conducted at Hospital Universitário de Santa Maria, Universidade Federal de Santa Maria (HUSM-UFSM) – Santa Maria (RS), Brazil.

Copyright © 2018. Anais Brasileiros de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.